| Bioactivity | DOCK2-IN-1 (compound 3), a CPYPP (HY-110100) analogue, is an inhibitor of DOCK2 as well (IC50=19.1 μM). DOCK2-IN-1 binds to DOCK2 DHR-2 domain in a reversible manner to inhibits its catalytic activity. DOCK2-IN-1 blocks the activation of both chemokine receptor- and antigen receptor-mediated Rac in lymphocytes. DOCK2-IN-1 significantly suppresses chemotactic response and T cell activation[1]. | ||||||||||||
| Name | DOCK2-IN-1 | ||||||||||||
| CAS | 4590-86-7 | ||||||||||||
| Formula | C16H11ClN2O2 | ||||||||||||
| Molar Mass | 298.72 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Nishikimi A, et al. Blockade of inflammatory responses by a small-molecule inhibitor of the Rac activator DOCK2. Chem Biol. 2012 Apr 20;19(4):488-97. |
DOCK2-IN-1
CAS: 4590-86-7 F: C16H11ClN2O2 W: 298.72
DOCK2-IN-1 (compound 3), a CPYPP (HY-110100) analogue, is an inhibitor of DOCK2 as well (IC50=19.1 μM). DOCK2-IN-1 bind
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.